These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21083037)

  • 1. Follicular lymphoma: emerging therapeutic strategies.
    Kenkre VP; Kahl BS
    Expert Rev Hematol; 2010 Aug; 3(4):485-95. PubMed ID: 21083037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic advances for indolent lymphomas].
    Ogura M
    Nihon Rinsho; 2000 Mar; 58(3):682-94. PubMed ID: 10741147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indolent lymphomas: current and emerging treatment approaches.
    Maloney D; Kahl BS; Dreyling M
    Clin Adv Hematol Oncol; 2006 Sep; 4(9 Suppl 20):1-10; quiz 11-2. PubMed ID: 17139243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the best initial therapy for a patient with symptomatic low-grade follicular lymphoma?
    Kenkre VP; Kahl BS
    Cancer J; 2012; 18(5):383-9. PubMed ID: 23006941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bendamustine's emerging role in the management of lymphoid malignancies.
    Rummel MJ; Gregory SA
    Semin Hematol; 2011 Apr; 48 Suppl 1():S24-36. PubMed ID: 21530769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advances in therapy of follicular lymphoma].
    Liu XX; Wang LN; Yang WL; Xi YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):250-4. PubMed ID: 24598689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current controversies in follicular lymphoma.
    Aurora V; Winter JN
    Blood Rev; 2006 Jul; 20(4):179-200. PubMed ID: 16410034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology and treatment of follicular lymphoma.
    Piccaluga PP; Sapienza MR; Agostinelli C; Sagramoso C; Mannu C; Sabattini E; Zinzani PL; Pileri SA
    Expert Rev Hematol; 2009 Oct; 2(5):533-47. PubMed ID: 21083019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marrow-ablative treatment and autologous stem cell transplantation in follicular NHL.
    Bachy E; Salles G
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):257-70. PubMed ID: 21658622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of hematopoietic cell transplantation for follicular non-Hodgkin's lymphoma.
    Laport GG
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):59-65. PubMed ID: 16399587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current immunochemotherapy strategies in follicular lymphoma.
    Giné E; Gutiérrez-García G; López-Guillermo A
    Adv Ther; 2010 Oct; 27(10):704-13. PubMed ID: 20820973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab maintenance versus retreatment in follicular lymphoma.
    Palla AR; Hamadani M
    Hematol Oncol; 2013 Dec; 31(4):171-8. PubMed ID: 23044794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.
    Cohen Y; Solal-Céligny P; Polliack A
    Haematologica; 2003 Jul; 88(7):811-23. PubMed ID: 12857561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.
    Zinzani PL; Marchetti M; Billio A; Barosi G; Carella AM; Lazzarino M; Martelli M; Rambaldi A; Rigacci L; Tarella C; Vitolo U; Tura S;
    Am J Hematol; 2013 Mar; 88(3):185-92. PubMed ID: 23339086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review.
    Oliansky DM; Gordon LI; King J; Laport G; Leonard JP; McLaughlin P; Soiffer RJ; van Besien KW; Werner M; Jones RB; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):443-68. PubMed ID: 20114084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
    Naparstek E
    Curr Hematol Rep; 2005 Jul; 4(4):276-83. PubMed ID: 16009042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in autologous stem cell transplantation for follicular lymphoma.
    Schmitz N
    Anticancer Drugs; 2001 Jun; 12 Suppl 2():S21-4. PubMed ID: 11508933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation.
    Puig N; Caballero MD; Alcoceba M; Sebastián E; Balanzategui A; Sarasquete ME; García-Sanz R; González-Díaz M
    Ann Hematol; 2011 Feb; 90(2):227-9. PubMed ID: 20506021
    [No Abstract]   [Full Text] [Related]  

  • 20. New agents in follicular lymphoma.
    Cheson BD
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):305-12. PubMed ID: 21658626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.